Your browser doesn't support javascript.
loading
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial.
Ware, Lorraine B; Soleymanlou, Nima; McAuley, Danny Francis; Estrada, Vicente; Diaz, George A; Lacamera, Peter; Kaste, Renee; Choi, Wansuk; Gupta, Abhya; Welte, Tobias.
Affiliation
  • Ware LB; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA lorraine.ware@vanderbilt.edu.
  • Soleymanlou N; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • McAuley DF; TA Cardio-Metabolism & Respiratory, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA.
  • Estrada V; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast Wellcome-Wolfson Institute for Experimental Medicine, Belfast, UK.
  • Diaz GA; Hospital Clínico San Carlos, IdISSC; CIBERINFE, Madrid, Spain.
  • Lacamera P; Section of Infectious Diseases, Providence Regional Medical Center Everett, Everett, Washington, USA.
  • Kaste R; Division of Pulmonary and Critical Care Medicine, St Elizabeth's Medical Center, Boston, Massachusetts, USA.
  • Choi W; TA Cardio-Metabolism & Respiratory, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA.
  • Gupta A; TA Cardio-Metabolism & Respiratory, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA.
  • Welte T; TA Inflammation Medicine, Boehringer Ingelheim International GmbH, Biberach an der Riss, Germany.
Thorax ; 78(8): 816-824, 2023 08.
Article in En | MEDLINE | ID: mdl-37024277

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Thorax Year: 2023 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Thorax Year: 2023 Document type: Article Affiliation country: Estados Unidos